Lynda M. Cristiano

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Johnny Mahlangu, Jerry S. Powell, Margaret V. Ragni et al. · Blood · 2013 · 441 citations · Full text

Medicine, Hematology, Molecular Biology +14

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 352 citations · Full text

Medicine, Hematology, Immunology +14

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A

Guy Young, Johnny Mahlangu, Roshni Kulkarni et al. · Journal of Thrombosis and Haemostasis · 2015 · 169 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

Paul O’Connor, Andrew Goodman, Ludwig Kappos et al. · Neurology · 2014 · 136 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study

Susan Friend, Sandra Richman, Gary Bloomgren et al. · BMC Neurology · 2016 · 131 citations · Full text

Medicine, Immunology, Obstetrics +17